CYTOKINETICS INC (CYTK) Stock Analyst Earnings Estimates
NASDAQ:CYTK - Nasdaq - US23282W6057 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 70.4M 26.16% | 94.6M 34.38% | 7.53M -92.04% | 6.461M -14.20% | 52.387M 710.82% | 310.1M 491.94% | 807.43M 160.38% | 1.42B 75.87% | 2.084B 46.76% | 2.734B 31.19% | 3.164B 15.73% | 3.639B 15.01% | |
| EBITDA YoY % growth | -184.02M -99.87% | -318.39M -73.02% | -484.313M -52.11% | -537.949M -11.07% | -591.961M -10.04% | -435.773M 26.38% | 231.11M 153.03% | 420.8M 82.08% | 702.86M 67.03% | 757.08M 7.71% | N/A | N/A | |
| EBIT YoY % growth | -186.3M -98.40% | -324.2M -74.02% | -496.205M -53.06% | -544.355M -9.70% | -603.362M -10.84% | -435.95M 27.75% | -166.106M 61.90% | 275.64M 265.94% | 728.97M 164.46% | 1.151B 57.89% | 1.555B 35.10% | 1.947B 25.21% | |
| Operating Margin | -264.63% | -342.71% | -6,589.71% | -8,425.24% | -1,151.74% | -140.58% | -20.57% | 19.41% | 34.98% | 42.10% | 49.15% | 53.50% | |
| EPS YoY % growth | -2.83 -40.80% | -4.22 -49.12% | -5.45 -29.15% | -5.34 1.94% | -5.50 -2.98% | -4.13 24.97% | -1.00 75.88% | 1.70 270.78% | 4.49 164.15% | 6.91 53.65% | 9.42 36.37% | 12.07 28.13% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.24 9.78% | -1.39 -4.81% | -1.41 -7.97% | -1.45 -6.50% | -1.36 -9.62% | -1.12 19.51% | -1.06 25.00% | -0.90 38.03% | -0.65 52.17% |
| Revenue Q2Q % growth | 1.719M 2.81% | 408K -51.14% | 1.428M 473.49% | 2.917M 530.02% | 17.051M 891.91% | 31.253M 7,560.05% | 46.879M 3,182.84% | 70.319M 2,310.66% | 108.63M 537.09% |
| EBITDA Q2Q % growth | -138.175M -19.61% | -151.072M -21.93% | -154.703M -23.33% | -161.578M -20.89% | -155.162M -12.29% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -141.733M -11.23% | -159.953M -26.71% | -162.378M -24.74% | -167.988M -19.31% | -161.71M -14.09% | -154.299M 3.53% | -146.883M 9.54% | -132.92M 20.88% | -106.289M 34.27% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.36 -0.74% | -1.27 | -0.09 | -6.82% |
| Q2 2024 Q2Q % growth | -1.31 2.24% | -1.08 | -0.23 | -21.59% |
| Q1 2024 Q2Q % growth | -1.33 3.62% | -1.16 | -0.17 | -14.19% |
| Q4 2023 Q2Q % growth | -1.38 4.83% | -0.99 | -0.39 | -39.39% |
| Q3 2023 Q2Q % growth | -1.35 11.18% | -0.76 | -0.59 | -78.29% |
| Q2 2023 Q2Q % growth | -1.34 -482.61% | -1.17 | -0.17 | -14.64% |
| Q1 2023 Q2Q % growth | -1.38 -35.29% | -1.22 | -0.16 | -12.82% |
| Q4 2022 Q2Q % growth | -1.45 -302.78% | -1.23 | -0.22 | -17.89% |
| Q3 2022 Q2Q % growth | -1.52 -60.00% | -1.19 | -0.33 | -27.35% |
| Q2 2022 Q2Q % growth | -0.23 73.26% | -1.04 | 0.81 | 77.91% |
| Q1 2022 Q2Q % growth | -1.02 -54.55% | -0.96 | -0.06 | -5.96% |
| Q4 2021 Q2Q % growth | -0.36 41.94% | -0.86 | 0.50 | 57.99% |
| Q3 2021 Q2Q % growth | -0.95 -1,800.00% | -0.79 | -0.16 | -20.57% |
| Q2 2021 Q2Q % growth | -0.86 -26.47% | -0.67 | -0.19 | -27.75% |
| Q1 2021 Q2Q % growth | -0.66 | -0.60 | -0.06 | -10.85% |
| Q4 2020 Q2Q % growth | -0.62 -19.23% | -0.31 | -0.31 | -101.77% |
| Q3 2020 Q2Q % growth | -0.05 90.00% | -0.34 | 0.29 | 85.48% |
| Q2 2020 Q2Q % growth | -0.68 -21.43% | -0.58 | -0.10 | -17.25% |
| Q1 2020 Q2Q % growth | -0.66 -22.22% | -0.51 | -0.15 | -29.85% |
| Q4 2019 Q2Q % growth | -0.52 | -0.45 | -0.07 | -15.86% |
| Q3 2019 Q2Q % growth | -0.50 | -0.50 | 0.00 | 0.37% |
| Q2 2019 Q2Q % growth | -0.56 | -0.51 | -0.05 | -10.69% |
| Q1 2019 Q2Q % growth | -0.54 | -0.48 | -0.06 | -12.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 463K 22.49% | 1.219M | -756K | -62.02% |
| Q2 2024 Q2Q % growth | 249K -71.28% | 940.012K | -691.012K | -73.51% |
| Q1 2024 Q2Q % growth | 835K -81.90% | 917.612K | -82.612K | -9.00% |
| Q4 2023 Q2Q % growth | 1.672M -14.69% | 10.985M | -9.313M | -84.78% |
| Q3 2023 Q2Q % growth | 378K -85.00% | 20.649M | -20.271M | -98.17% |
| Q2 2023 Q2Q % growth | 867K -99.03% | 5.92M | -5.053M | -85.35% |
| Q1 2023 Q2Q % growth | 4.613M 301.13% | 2.131M | 2.482M | 116.47% |
| Q4 2022 Q2Q % growth | 1.96M -96.47% | 7.241M | -5.281M | -72.93% |
| Q3 2022 Q2Q % growth | 2.52M -53.68% | 3.017M | -497K | -16.47% |
| Q2 2022 Q2Q % growth | 88.97M 3,032.75% | 3.704M | 85.266M | 2,302.00% |
| Q1 2022 Q2Q % growth | 1.15M -82.44% | 4.924M | -3.774M | -76.65% |
| Q4 2021 Q2Q % growth | 55.6M 727.38% | 6.321M | 49.279M | 779.61% |
| Q3 2021 Q2Q % growth | 5.44M -86.95% | 6.465M | -1.025M | -15.85% |
| Q2 2021 Q2Q % growth | 2.84M -20.89% | 5.559M | -2.719M | -48.91% |
| Q1 2021 Q2Q % growth | 6.55M 71.02% | 6.715M | -165K | -2.46% |
| Q4 2020 Q2Q % growth | 6.72M 28.98% | 8.729M | -2.009M | -23.02% |
| Q3 2020 Q2Q % growth | 41.69M 587.95% | 4.097M | 37.593M | 917.57% |
| Q2 2020 Q2Q % growth | 3.59M -49.72% | 4.154M | -564K | -13.58% |
| Q1 2020 Q2Q % growth | 3.83M -54.73% | 5.106M | -1.276M | -24.99% |
| Q4 2019 Q2Q % growth | 5.21M | 7.339M | -2.129M | -29.01% |
| Q3 2019 Q2Q % growth | 6.06M | 7.67M | -1.61M | -20.99% |
| Q2 2019 Q2Q % growth | 7.14M | 7.13M | 10K | 0.14% |
| Q1 2019 Q2Q % growth | 8.46M | 6.999M | 1.461M | 20.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 5.34% | -10.72% | 0.51% | -1.06% |
| Revenue | -13.83% | 85.52% | -0.69% | -13.67% |